A 49-year-old woman was admitted tothe hospital with a high fever ofabrupt onset, rigor, headache, myalgias,and profound prostration. Hertemperature was 41ºC (105.8ºF);blood pressure, 60/40 mm Hg; respirationrate, 30 breaths per minute;and pulse rate, 130 beats per minute.
A 49-year-old woman was admitted tothe hospital with a high fever ofabrupt onset, rigor, headache, myalgias,and profound prostration. Hertemperature was 41C (105.8F);blood pressure, 60/40 mm Hg; respirationrate, 30 breaths per minute;and pulse rate, 130 beats per minute.Extensive purpuric patches andlarge ecchymoses were noted on thelower extremities and the buttocks.Signs of meningeal irritation wereabsent. Analysis of a specimen of cerebrospinal fluid wasunremarkable; blood cultures revealed an infection causedby Neisseria meningitidis.s patient was given ceftriaxone,2 g bid, and penicillin, 24 million U/d; she was dischargedfrom the hospital after 10 days.Patients with meningococcemia may not demonstratemeningeal signs; however, 50% to 80% will present withpetechiae and purpuric skin lesions.1 Thus, a careful examinationof the skin and mucosal surfaces is warrantedin the acutely ill febrile patient.
REFERENCE:
1.
Rosenstein NE, Perkins BA, Stephens DS, et al. Meningococcal disease.
N Engl J Med.
2001;344:1378-1388.(Case and photograph courtesy of Drs Evagelos Liberopoulos, Dimitris Christidis,and Moses Elisaf.)
Lebrikizumab Demonstrates Efficacy, Safety in Patients With Skin of Color With AD
June 11th 2025RAD 2025. Lebrikizumab improved skin clearance, itch, and pigmentation in patients with skin of color and atopic dermatitis, with strong safety data through 24 weeks, according to late-breaking data.